The Federal Trade Commission has given the green light to Amgen's purchase of Horizon Therapeutics.

Share:
More In Business
Stocks on Pace for Winning Session Amid Upbeat Economic Data
As the first half of the year comes to a close, a mixed market kicks off with the Nasdaq on pace for its best quarter in nearly four decades while the stock market looks to get its first positive session in seven tries as upbeat economic data comes in.
Load More